Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features.
Arduino PG, Porter SR.
J Oral Pathol Med. 2008 Feb;37(2):107-21. doi: 10.1111/j.1600-0714.2007.00586.x.
Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management.
Fatahzadeh M, Schwartz RA.
J Am Acad Dermatol. 2007 Nov;57(5):737-63; quiz 764-6. doi: 10.1016/j.jaad.2007.06.027.
The many challenges of facial herpes simplex virus infection.
Esmann J.
J Antimicrob Chemother. 2001 Feb;47 Suppl T1:17-27. doi: 10.1093/jac/47.suppl_1.17.
Facial paralysis induced by ear inoculation of herpes simplex virus in rat.
Fujiwara T, Matsuda S, Tanaka J, Hato N.
Auris Nasus Larynx. 2017 Feb;44(1):58-64. doi: 10.1016/j.anl.2016.04.002. Epub 2016 Apr 17.
The natural history of recurrent oral-facial herpes simplex virus infection.
Spruance SL.
Semin Dermatol. 1992 Sep;11(3):200-6.
Improving the outcome of facial resurfacing--prevention of herpes simplex virus type 1 reactivation.
Gilbert S.
J Antimicrob Chemother. 2001 Feb;47 Suppl T1:29-34. doi: 10.1093/jac/47.suppl_1.29.
Herpes simplex virus reactivation after nonablative fractional laser to treat facial photoaging.
Tang Q, Che Q, Xie Y, Xie L, Liu L, Gao Y, Zhou Z, Wa Q.
J Cosmet Laser Ther. 2024 Jan-Jun;26(1-4):86-88. doi: 10.1080/14764172.2024.2370418. Epub 2024 Jun 24.
Risk factors of facial herpes simplex after percutaneous microballoon compression for trigeminal neuralgia: A retrospective case-cohort study.
Zhang A, Li Q, Wang H, Huang H, Zhang H.
Neuro Endocrinol Lett. 2023 Mar 8;44(1):31-38.
[Herpes simplex prophylaxis in facial exfoliation treatments].
Guerra A, Cisneros JL, Eiros JM, Herrera E, Jaén P, Pérez-Macías JM.
Actas Dermosifiliogr. 2005 Oct;96(8):479-97. doi: 10.1016/s0001-7310(05)73120-3.
Herpes simplex neuropathy.
Krohel GB, Richardson JR, Farrell DF.
Neurology. 1976 Jun;26(6 PT 1):596-7. doi: 10.1212/wnl.26.6.596.
